The use of opioids in oncologic palliative care: A literature review
DOI:
https://doi.org/10.33448/rsd-v13i6.45987Keywords:
Opioid; Integrative Palliative Care; Cancer Pain; Pain Management.Abstract
Introduction: pain represents a frequent consequence, both of the cancer pathological process and its treatment. Oncological pain management requires a multidisciplinary and integrated approach, ensuring individualized care and continuous supervision, as the vast majority of patients require opioid use. Objective: to analyze the role of opioids in different strategies for managing oncological pain in palliative care patients. Methodology: this is a integrative literature review. Results: twenty studies were selected for the composition of this study, covering 10 different countries and various methodologies, including cross-sectional studies, randomized trials, cohort studies, and case series. Discussion: pain is a common complaint among oncology patients in palliative care. Clinical protocols recommend opioid use as first-line analgesia in severe cases, with the possibility of adjusting and escalating treatment as needed. Additionally, other drugs are being tested as adjuvants, which may improve the pain management experience. Final considerations: palliative care is essential in cancer management, aiming to improve the quality of life for patients and their families. An integrated and multidisciplinary approach is necessary to manage oncological pain, considering its various impacts. Adjustments in opioid dosage and the use of other medication classes are being investigated to enhance pain relief.
References
Banala, S. R., Khattab, O. K., Page, V. D., Warneke, C. L., Todd, K. H., & Yeung, S. C. J. (2020). Intranasal fentanyl spray versus intravenous opioids for the treatment of severe pain in patients with cancer in the emergency department setting: A randomized controlled trial. Plos one, 15(7), e0235461.
Castiblanco-Delgado, D. S., Seija-Butnaru, D., & Molina-Arteta, B. M. (2022). Intravenous lidocaine in cancer-related neuropathic pain: case series. Colombian Journal of Anestesiology, 50(2).
Corli, O., Santucci, C., Corsi, N., Radrezza, S., Galli, F., & Bosetti, C. (2019). The burden of opioid adverse events and the influence on cancer patients' symptomatology. Journal of pain and symptom management, 57(5), 899-908.
Corli, O., Roberto, A., Corsi, N., Galli, F., & Pizzuto, M. (2018). Opioid switching and variability in response in pain cancer patients. Supportive Care in Cancer, 27, 2321-2327.
Edler-Buggy, S., Birtwistle, J., ElMokhallalati, Y., Kindl, K., Good, P., & Bennett, M. I. (2020). Regular dosing compared with as-needed dosing of opioids for management of chronic cancer pain: systematic review and meta-analysis. Pain, 161(4), 703-712.
Freitas, B. F., Castro, C. S., Alves, E. L., de Barcelos Mota, E. M., de Brito, I. E., Miranda, M. A., ... & de Aquino, R. L. (2023). O uso dos operadores como estratégia de busca em revisões de literatura científica. Brazilian Journal of Implantology and Health Sciences, 5(3), 652-664.
Gibbons, K., DeMonbrun, A., Beckman, E. J., Keefer, P., Wagner, D., Stewart, M., ... & Niedner, M. (2016). Continuous lidocaine infusions to manage opioid‐refractory pain in a series of cancer patients in a pediatric hospital. Pediatric Blood & Cancer, 63(7), 1168-1174.
González-Barboteo, J., Porta-Sales, J., Nabal-Vicuña, M., Díez-Porres, L., Canal-Sotelo, J., Alonso-Babarro, A., ... & Bruera, E. (2021). Switching ratio from parenteral to oral methadone 1: 1.2 is safer compared with ratio 1: 2 in patients with controlled cancer pain: a multicenter randomized-controlled trial. Journal of palliative medicine, 24(3), 382-390.
Haumann, J., Geurts, J. W., Van Kuijk, S. M. J., Kremer, B., Joosten, E. A., & van den Beuken-van Everdingen, M. H. J. (2016). Methadone is superior to fentanyl in treating neuropathic pain in patients with head-and-neck cancer. European Journal of Cancer, 65, 121-129.
Hassankhani, H., Rahmani, A., Taleghani, F., Sanaat, Z., & Dehghannezhad, J. (2020). Palliative care models for cancer patients: Learning for planning in nursing. Journal of Cancer Education, 35, 3-13.
Hawley, P., Fyles, G., & Jefferys, S. G. (2020). Subcutaneous lidocaine for cancer-related pain. Journal of Palliative Medicine, 23(10), 1357-1364.
Jamieson, L., Harrop, E., Johnson, M., Liossi, C., Mott, C., Oulton, K., ... & Howard, R. F. (2021). Healthcare professionals’ views of the use of oral morphine and transmucosal diamorphine in the management of paediatric breakthrough pain and the feasibility of a randomised controlled trial: A focus group study (DIPPER). Palliative Medicine, 35(6), 1118-1125.
Mendes, T. R., Boaventura, R. P., Castro, M. C., & Mendonça, M. A. O. (2014). Ocorrência da dor nos pacientes oncológicos em cuidado paliativo. Acta paulista de enfermagem, 27, 356-361.
Mercadante, S., Adile, C., Cuomo, A., Aielli, F., Cortegiani, A., Casuccio, A., & Porzio, G. (2015). Fentanyl buccal tablet vs. oral morphine in doses proportional to the basal opioid regimen for the management of breakthrough cancer pain: a randomized, crossover, comparison study. Journal of pain and symptom management, 50(5), 579-586.
Mercadante, S., Adile, C., Tirelli, W., Ferrera, P., Penco, I., & Casuccio, A. (2021). Barriers and adherence to pain management in advanced cancer patients. Pain Practice, 21(4), 388-393.
Mercadante, S., Adile, C., Ferrera, P., Pallotti, M. C., Ricci, M., Bonanno, G., & Casuccio, A. (2022). Methadone as first-line opioid for the management of cancer pain. The Oncologist, 27(4), 323-327.
Paice, J. A., Bohlke, K., Barton, D., Craig, D. S., El-Jawahri, A., Hershman, D. L., ... & Bruera, E. (2023). Use of opioids for adults with pain from cancer or cancer treatment: ASCO guideline. Journal of Clinical Oncology, 41(4), 914-930.
Porta-Sales, J., Garzón-Rodríguez, C., Villavicencio-Chávez, C., Llorens-Torromé, S., & González-Barboteo, J. (2016). Efficacy and safety of methadone as a second-line opioid for cancer pain in an outpatient clinic: A prospective open-label study. The Oncologist, 21(8), 981-987.
Reddy, A., Yennurajalingam, S., Desai, H., Reddy, S., Cruz, M., Wu, J., ... & Bruera, E. (2014). The opioid rotation ratio of hydrocodone to strong opioids in cancer patients. The oncologist, 19(11), 1186-1193.
Sampaio, S. G. D. S. M., da Motta, L. B., & Caldas, C. P. (2019). Medicamentos e Controle de dor: Experiência de um Centro de Referência em Cuidados Paliativos no Brasil. Revista Brasileira de Cancerologia, 65(2).
Sampaio, S. G. D. S. M., da Motta, L. B., & Caldas, C. P. (2021). Dor e Internação Hospitalar em Cuidados Paliativos. Revista Brasileira de Cancerologia, 67(3).
Santos, C. M., de Mattos Pimenta, C. A., & Nobre, M. R. C. (2007). A estratégia PICO para a construção da pergunta de pesquisa e busca de evidências. Revista Latino-Americana de Enfermagem, 15(3).
Souza, M. T. D., Silva, M. D. D., & Carvalho, R. D. (2010). Integrative review: what is it? How to do it?. Einstein (São Paulo), 8, 102-106.
Takigawa, C., Goto, F., Tanda, S., Shima, Y., Yomiya, K., Matoba, M., ... & Eguchi, K. (2015). Breakthrough pain management using fentanyl buccal tablet (FBT) in combination with around-the-clock (ATC) opioids based on the efficacy and safety of FBT, and its relationship with ATC opioids: results from an open-label, multi-center study in Japanese cancer patients with detailed evaluation. Japanese Journal of Clinical Oncology, 45(1), 67-74.
Yen, T. Y., Chiou, J. F., Chiang, W. Y., Su, W. H., Huang, M. Y., Hu, M. H., ... & Lai, Y. L. (2018). Proportional dose of rapid-onset opioid in breakthrough cancer pain management: An open-label, multicenter study. Medicine, 97(30), e11593.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Vitória Rodrigues Franco da Rosa; Estela Rezende Pereira; Júnia Flávia Aparecida Pereira Canaan; Larissa Mirelle de Oliveira Pereira
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
